Stocks / Pharmaceuticals

CAPRPharmaceuticals

Capricor Therapeutics Inc
$9.451d +8.0%5d +14.0%settled close · 2026-09-17
Mkt cap $1.7B (3/25)β 1.3252w $3.85–36Shares 57.5MInd. Pharmaceutical PreparationsNasdaq since 2002Emp. 231HQ San Diego, CAcapricor.com
Who’s talkingIdea Scout · free

Who’s talking about CAPR

No tracked investor commentary on CAPR yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 9 Nov 2026

Confirmed date · consensus EPS -0.44. Reactions below are the next settled session over the prior close.
ReportWhenEPS actual vs est.Reaction
13 Aug 2026after the close-0.70 vs -0.60-7.7%
The options tape

Notable options days

Sessions in the last 120 where CAPR’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 21 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-08-27
2026-08-25
2026-08-24
2026-08-14
2026-07-30
2026-07-28
2026-07-27
2026-07-24
2026-07-08
2026-07-06
2026-06-30
2026-06-29
2026-06-26
2026-06-22
2026-06-17
2026-05-12
2026-05-11
2026-04-17
2026-04-15
2026-04-14
2026-04-13
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on CAPR is in this morning’s Brief. Get The Brief — $20/mo →